Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.732,66
-0,25%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Repligen Corp (RGEN) Repligen Corp (RGEN) Notizie

Repligen Corp

RGEN
167,05
0,74 (0,44%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202413:30GLOBERepligen Reports First Quarter 2024 Financial Results
17/4/202413:30GLOBERepligen to Report First Quarter 2024 Financial Results
19/3/202412:30GLOBERepligen Appoints Maggie A. Pax to Board of Directors
11/3/202421:12EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:17EDGAR2Form 144 - Report of proposed sale of securities
07/3/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202403:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202403:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202403:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202403:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:59EDGAR2Form 144 - Report of proposed sale of securities
27/2/202402:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202421:29EDGAR2Form 144 - Report of proposed sale of securities
22/2/202422:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202413:47EDGAR2Form 8-K - Current report
21/2/202413:30GLOBERepligen Reports Fourth Quarter and Full Year 2023 Financial..
07/2/202413:30GLOBERepligen to Report Fourth Quarter and Full Year 2023..
06/2/202419:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202417:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/12/202313:30GLOBERepligen Corporation to Present at 42nd Annual J.P. Morgan..
16/12/202301:04EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15/12/202322:33EDGAR2Form 8-K - Current report
07/12/202313:39EDGAR2Form 8-K - Current report
07/12/202313:30GLOBERepligen Announces Private Convertible Transaction of $600..
16/11/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202320:01GLOBEUPDATE – Repligen Announces Publication of the Company’s..
14/11/202313:30GLOBERepligen Announces Publication of the Company’s 2022..
13/11/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202317:56EDGAR2Form 144 - Report of proposed sale of securities
07/11/202313:30GLOBERepligen Corporation to Present at Upcoming Investor..
02/11/202312:30GLOBERepligen Launches TangenX® SC as First-to-Market Holder-Free..
31/10/202321:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202312:48EDGAR2Form 8-K - Current report
31/10/202312:30GLOBERepligen Reports Third Quarter 2023 Financial Results and..
17/10/202313:30GLOBERepligen to Report Third Quarter 2023 Financial Results
04/10/202302:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 170,10 Min: 166,43 Max: 172,00
Chiusura: 166,31

La tua Cronologia

NASDAQ
RGEN
Repligen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network